(Q30643697)

25 June 2017

1 reference

title

Sleep in fibromyalgia: review of clinical and polysomnographic data (English)

1 reference

25 June 2017

0 references

0 references

Dauvilliers Y

1

1 reference

25 June 2017

Touchon J

series ordinal

2

1 reference

25 June 2017

publication date

1 February 2001

1 reference

Neurophysiologie Clinique

25 June 2017

published in

1 reference

25 June 2017

volume

31

1 reference

25 June 2017

issue

1

1 reference

25 June 2017

page(s)

18-33

1 reference

A model of human sleep homeostasis based on EEG slow-wave activity: quantitative comparison of data and simulations

25 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2800%2900240-9

7 January 2021

Sequential daily relations of sleep, pain intensity, and attention to pain among women with fibromyalgia.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2800%2900240-9

7 January 2021

The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2800%2900240-9

7 January 2021

Sleep physiology and psychological aspects of the fibrositis (fibromyalgia) syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2800%2900240-9

7 January 2021

A comparison of cyclobenzaprine and placebo in the management of fibrositis. A double-blind controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2800%2900240-9

7 January 2021

Low levels of somatomedin C in patients with the fibromyalgia syndrome. A possible link between sleep and muscle pain.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2800%2900240-9

7 January 2021

A randomized, double-blind, placebo-controlled study of growth hormone in the treatment of fibromyalgia.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2800%2900240-9

7 January 2021

Clinical characteristics of fibrositis. I. A "blinded," controlled study of symptoms and tender points

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2800%2900240-9

7 January 2021

Evaluation of amitriptyline in primary fibrositis. A double-blind, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2800%2900240-9

7 January 2021

Sleep electroencephalography and the clinical response to amitriptyline in patients with fibromyalgia.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2800%2900240-9

7 January 2021

Neuroendocrine abnormalities in fibromyalgia and related disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2800%2900240-9

7 January 2021

Electroacupuncture in fibromyalgia: results of a controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2800%2900240-9

7 January 2021

Fibromyalgia disclosing syndrome of periodic movements during sleep

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2800%2900240-9

7 January 2021

Sleep intensity in fibromyalgia: focus on the microstructure of the sleep process.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2800%2900240-9

7 January 2021

The effect of cutaneous and deep pain on the electroencephalogram during sleep--an experimental study

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2800%2900240-9

7 January 2021

Chronic fatigue syndrome differs from fibromyalgia. No evidence for elevated substance P levels in cerebrospinal fluid of patients with chronic fatigue syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2800%2900240-9

7 January 2021

The occurrence of fibromyalgia-like syndromes in a general female population.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2800%2900240-9

7 January 2021

Pharmacotherapeutics in fibrositis.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2800%2900240-9

7 January 2021

A randomized, controlled trial of amitriptyline and naproxen in the treatment of patients with fibromyalgia

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2800%2900240-9

7 January 2021

Fibromyalgia syndrome. An emerging but controversial condition

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2800%2900240-9

7 January 2021

A Lecture on Lumbago: Its Lessons and Analogues: Delivered at the National Hospital for the Paralysed and Epileptic

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2800%2900240-9

7 January 2021

Effect of zopiclone on sleep quality, morning stiffness, widespread tenderness and pain and general discomfort in primary fibromyalgia patients. A double-blind randomized trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2800%2900240-9

7 January 2021

Sleep in fibromyalgia patients: subjective and objective findings.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2800%2900240-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0987-7053%2800%2900240-9

1 reference

7 January 2021

Objective and subjective sleep disturbances in patients with rheumatoid arthritis. A reappraisal.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2800%2900240-9

7 January 2021

Alpha-like EEG activity in non-REM sleep and the fibromyalgia (fibrositis) syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2800%2900240-9

7 January 2021

Comorbidity of fibromyalgia with medical and psychiatric disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2800%2900240-9

7 January 2021

Cerebral dysfunction in fibromyalgia: evidence from regional cerebral blood flow measurements, otoneurological tests and cerebrospinal fluid analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2800%2900240-9

7 January 2021

A prospective long-term study of fibromyalgia syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2800%2900240-9

7 January 2021

Fibromyalgia syndrome: overnight falls in arterial oxygen saturation

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2800%2900240-9

7 January 2021

Lack of association between fibromyalgia and sleep apnoea syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2800%2900240-9

7 January 2021

Circadian studies of autonomic nervous balance in patients with fibromyalgia: a heart rate variability analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2800%2900240-9

7 January 2021

Prevalence of primary fibromyalgia in the Finnish population

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2800%2900240-9

7 January 2021

Sleep apnea in male patients with the fibromyalgia syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2800%2900240-9

7 January 2021

Role of physical fitness training in the fibrositis/fibromyalgia syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2800%2900240-9

7 January 2021

A controlled study of the effects of a supervised cardiovascular fitness training program on the manifestations of primary fibromyalgia.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2800%2900240-9

7 January 2021

Musculosketal Symptoms and Non-REM Sleep Disturbance in Patients with “Fibrositis Syndrome” and Healthy Subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2800%2900240-9

7 January 2021

Induction of Neurasthenic Musculoskeletal Pain Syndrome by Selective Sleep Stage Deprivation

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2800%2900240-9

7 January 2021

The relationship of alpha and delta EEG frequencies to pain and mood in ‘fibrositis’ patients treated with chlorpromazine and l-tryptophan

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2800%2900240-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2800%2900240-9

7 January 2021

Fibrositis and psychologic disturbance

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2800%2900240-9

7 January 2021

A reconceptualization of EEG alpha activity as an index of arousal during sleep: all alpha activity is not equal.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2800%2900240-9

7 January 2021

Fibromyalgia falls foul of a fallacy

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2800%2900240-9

7 January 2021

Periodicity analysis of sleep EEG in the second and minute ranges — example of application in different alpha activities in sleep

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2800%2900240-9

7 January 2021

Referred pain and tender points

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2800%2900240-9

7 January 2021

Aircraft noise and mental health: I. Prevalence of individual symptoms.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2800%2900240-9

7 January 2021

Elevated CSF levels of substance P and high incidence of Raynaud phenomenon in patients with fibromyalgia: new features for diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2800%2900240-9

7 January 2021

Fibromyalgia and melatonin: are they related?

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2800%2900240-9

7 January 2021

Fibromyalgia--a syndrome associated with decreased nocturnal melatonin secretion.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2800%2900240-9

7 January 2021

The prevalence and characteristics of fibromyalgia in the general population.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2800%2900240-9

7 January 2021

Primary fibromyalgia (fibrositis): clinical study of 50 patients with matched normal controls

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2800%2900240-9

7 January 2021

Restless legs syndrome and leg cramps in fibromyalgia syndrome: a controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2800%2900240-9

7 January 2021

10.1016/S0987-7053(00)00240-9

Identifiers

DOI

1 reference

25 June 2017

1 reference